Related Experiment Video
Updated: Feb 12, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Extension Reports in Clinical Trials: A Systematic Review and Consequent Guidance
Xavier Rossello1, Stuart J Pocock2, Dylan Taylor3
1Cardiology Department, Hospital Universitari Son Espases, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma de Mallorca, Spain; Facultad de Medicina, Universitat Illes Balears (UIB), Palma de Mallorca, Spain; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
This study analyzed cardiovascular trial extension reports, finding diverse reporting practices and methodological issues. Improved guidelines are needed for planning, conducting, and reporting these crucial long-term studies.
Area of Science:
- Cardiology
- Clinical Trials
- Medical Research Methodology
Background:
- Long-term efficacy and safety of cardiovascular interventions often remain unclear after initial trial publication.
- Sequel publications with extended follow-up are common, but standardized reporting guidelines are lacking.
Purpose of the Study:
- To assess the characteristics of extension reports for cardiovascular trials.
- To identify common practices and potential issues in reporting extended follow-up data.
Main Methods:
- Systematic search of MEDLINE for cardiovascular trial extension papers published between January 2019 and October 2023 in 7 high-impact journals.
- Screening of 1,388 papers, with data extraction from 69 identified extension reports.
Main Results:
- 69 extension reports from 64 trials were identified, covering various cardiovascular topics, most commonly coronary heart disease.
- Significant diversity in follow-up duration, outcome reporting, and methodology (e.g., treatment crossovers, non-standard analyses) was observed.
- Many extension studies lacked prespecification, dedicated protocols, or multiplicity corrections, and some reported considerable loss to follow-up.
Conclusions:
- This systematic investigation revealed considerable diversity in the reporting of cardiovascular trial extension studies.
- Several methodological and reporting issues require greater attention to ensure the validity and interpretation of extended follow-up data.
- Recommendations are provided for planning, conducting, and reporting future extension studies.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Timing and Consequences on Behavior
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview

